Vox Markets Podcast 260719
Episode 1467, Jul 26, 2019, 11:49 AM
On Today’s Podcast: Chief Executive of Dev Clever (DEV), Chris Jeffries; Carl Sterrit, CEO of Shield Therapeutics (STX) and Nick Tulloch, Finance Director at Highland Natural Resources (HNR).
Chris Jeffries, CEO of Dev Clever touches on this morning’s interim results alongside the company’s recent contract wins.
Carl Sterritt, CEO of Shield Therapeutics discusses this morning’s news - a long awaited result for the company as US FDA approval was cleared for its lead product Feraccru.
Nick Tulloch, Finance Director at Highland Natural Resources discusses final results and how their latest business brand, Zoetic Organics, is establishing itself within the lucrative CBD market.
Chris Jeffries, CEO of Dev Clever touches on this morning’s interim results alongside the company’s recent contract wins.
Carl Sterritt, CEO of Shield Therapeutics discusses this morning’s news - a long awaited result for the company as US FDA approval was cleared for its lead product Feraccru.
Nick Tulloch, Finance Director at Highland Natural Resources discusses final results and how their latest business brand, Zoetic Organics, is establishing itself within the lucrative CBD market.